BOSTON, Oct. 28, 2019 /PRNewswire/ -- Medisafe, an evidence-based digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced ...
Medisafe, a technology vendor that markets a personalized medication management platform, has unveiled at HIMSS17 a new feature that alerts users of possible drug-to-drug interactions that may cause ...
BOSTON, Nov. 5, 2019 /PRNewswire/ -- Medisafe, an evidence-based digital therapeutics company providing medication management solutions for patients across the healthcare continuum, and Merck KGaA, ...
Medisafe, a digital medication adherence app, is joining forces with Amerisource Bergen’s Lash Group in order to integrate the former’s management app into the latter’s hub services. The partnership ...
As part of an initiative led by the ONC, Medisafe, a personalized medication management platform, demonstrated the functionality of its interoperable medication lists. Medisafe debuted the platform ...
BOSTON, MA / ACCESSWIRE / February 13, 2024 / A novel randomized control trial conducted by Vanderbilt University researchers and published in the Journal of Behavioral Medicine explored the effect of ...
BOSTON, June 30, 2021 /PRNewswire/ -- Medisafe, a leading digital drug companion company, today announced the findings from two validation studies examining the impact of its digital drug companion on ...
The company builds off 2022's milestones to level up for the next phase of company growth in industry leading patient engagement solutions. BOSTON, MA / ACCESSWIRE / February 28, 2023 / Medisafe, a ...
HAIFA, Israel--(BUSINESS WIRE)--MediSafe Project (www.MediSafeProject.com) announced today its users have a reported medication adherence rate of 81%. For Statins, the adherence rate climbs to 84.25%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback